FindTrial
Sign In

A study to investigate the Efficacy, Safety, Acceptability of Essilor® Stellest® Spectacle Lenses along with the testing of Quality of Life implications in slowing down Myopia progression, in children and adolescents in India.

A Multi-Centric, Retrospective, Real World Clinical follow-up study to demonstrate the Efficacy of Essilor® Stellest® Spectacle Lenses in slowing down Myopia progression in children and adolescents in India - SOLIDITY

Status
Unknown
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/08/071994
Enrollment
395
Registered
2024-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H521- Myopia

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Essilor® India Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Inclusion should be progressive myopia based on change in RE in the previous year 2. Information on progression of myopia prior to treatment should be available 3. All participants wearing Essilor® Stellest® Lenses

Exclusion criteria

Exclusion criteria: Not Applicable

Design outcomes

Primary

MeasureTime frame
To compare with change in SER over 1 year prior to use of Stellest lenses and Change in cycloplegic autorefraction (SER) from baseline upto 12 monthsTimepoint: Up to 12 months—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr Mukul Maurya

Essilor® India Private Limited

vijaya.v@essilorindia.com8197529017

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026